SPAC Overview
$200M
IPO Size
Withdrawn
Current Status
Timeline Progress
About
HighCape Capital Acquisition Corp. II is a blank-check company seeking to identify and acquire a life sciences or life sciences-related business. Its stated investment focus spans therapeutics, devices, diagnostics, medical information technology and digital health.
Investment Focus
Healthcare, Biopharmaceuticals
The terms and the filing trail behind HighCape Capital Acquisition Corp. II
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The management and sponsor team is led by Kevin Rakin and Matt Zuga, experienced life sciences executives and investors and HighCape co-founders. The board nominees bring substantial experience in biopharmaceuticals, medtech, business development and healthcare.
Key Information
SPAC Ticker
N/A